The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

18 articles for AA Szewczak


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
33
Potent benzoazepinone¿-secretase modulators with improved bioavailability.EBI
Merck Research Laboratories
8
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor.EBI
Merck Research Laboratories
39
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-Met.EBI
Merck
35
Triazoloamides as potent¿-secretase modulators with reduced hERG liability.EBI
Merck Research Laboratories
67
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer.EBI
Merck Research Laboratories
63
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).EBI
Merck Research Laboratories
2
Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1).EBI
Merck Research Laboratories
51
Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disorders.EBI
Merck
17
Triazoles as¿-secretase modulators.EBI
Merck Research Laboratories
18
Quinazolinones as¿-secretase modulators.EBI
Merck Research Laboratories
22
Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2).EBI
Merck Research Laboratories
39
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2).EBI
Merck Research Laboratories
42
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors.EBI
Merck Research Laboratories
7
Purine derivatives as potent gamma-secretase modulators.EBI
Merck Research Laboratories
8
Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators.EBI
Merck Research Laboratories
11
Fluorinated piperidine acetic acids as gamma-secretase modulators.EBI
Merck Research Laboratories
18
Aminoindazole derivatives as sodium channel inhibitorsBDB
Almirall